- Sputnik International, 1920
World
Get the latest news from around the world, live coverage, off-beat stories, features and analysis.

Skin Rash Identified as Potential Delayed Side Effect of Moderna Vaccine Shot, Study Shows

© AP Photo / Jean-Francois BadiasA man receives the Moderna COVID-19 vaccine at a vaccination center in Schiltigheim, eastern France, Thursday Jan. 28, 2021.
A man receives the Moderna COVID-19 vaccine at a vaccination center in Schiltigheim, eastern France, Thursday Jan. 28, 2021. - Sputnik International, 1920, 05.03.2021
Subscribe
MOSCOW (Sputnik) - A skin rash appearing around the injection site four to 11 days after the administration of the first dose could be a potential delayed reaction to the Moderna vaccine, a team of American doctors reported on March 3.

"We have ... observed delayed large local reactions to the mRNA-1273 vaccine, with a median onset on day 8 (range, 4 to 11) after the first dose," the report stated.

A worker of the New York City Fire Department Bureau of Emergency Medical Services (FDNY EMS) receives a COVID-19 Moderna vaccine, amid the coronavirus disease (COVID-19) pandemic in the Manhattan borough of New York City, New York, U.S., December 23, 2020 - Sputnik International, 1920, 22.01.2021
CDC: Less Than 1% of Those Who Received Moderna Vaccine Had Severe Reactions
In a study involving 30,000 recipients of the Moderna coronavirus vaccine, about 12 people had redness on their arms accompanied by sore, itchy or swollen patches of skin around a week after receiving the first dose. Five of those patients with a delayed reaction had large skin lesions over 10 centimeters (4 inches) in diameter surrounding the injection site.

According to the report, all symptoms were within the range of the expected side effects from the vaccination and were resolved quickly after appropriate treatment.

"Most patients received treatment for their symptoms (e.g., with ice and antihistamines) ... The symptoms resolved a median of 6 days after onset (range, 2 to 11)," the study said.

The doctors encouraged all 12 patients to continue with the second dose "given that neither local injection-site reactions nor delayed-type hypersensitivity reactions are contraindications to subsequent vaccination." Reportedly, half of the patients had no recurrence of the symptoms after the second dose, while the rest manifested similar reactions with lower intensity.

In the light of the global mass vaccination campaign, the study aimed to prepare local medical facilities for dealing with the possible delayed side effects and reassure the patients that the vaccine is safe.

Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала